Prophylactic administration of EPO has a role in preventing AKI, reducing cardiac complications and lowering the incidence of prolonged vasopressor dependence in patients suffering cardiovascular surgery (7, 24, 25). The gene discussed is EPO; the disease is acute kidney injury.